Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma

High risk neuroblastoma (HR-NB) remains difficult to treat, and its overall survival (OS) is still below 50%. Although HR-NB is a heterogeneous disease, HR-NB patients are currently treated in a similar fashion. Through unsupervised biclustering, we further stratified HR-NB patients into two reprodu...

Full description

Bibliographic Details
Main Authors: Zhenqiu Liu, Christa N. Grant, Lidan Sun, Barbara A. Miller, Vladimir S. Spiegelman, Hong-Gang Wang
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/7/1739
id doaj-0c51551304214d639eb94a18b5a44a4d
record_format Article
spelling doaj-0c51551304214d639eb94a18b5a44a4d2020-11-25T03:12:43ZengMDPI AGCancers2072-66942020-06-01121739173910.3390/cancers12071739Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk NeuroblastomaZhenqiu Liu0Christa N. Grant1Lidan Sun2Barbara A. Miller3Vladimir S. Spiegelman4Hong-Gang Wang5Department of Public Health Sciences, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USADivision of Pediatric Surgery, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USADepartment of Public Health Sciences, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USADivision of Pediatric Hematology and Oncology, Department of Pediatrics, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USADivision of Pediatric Hematology and Oncology, Department of Pediatrics, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USADivision of Pediatric Hematology and Oncology, Department of Pediatrics, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USAHigh risk neuroblastoma (HR-NB) remains difficult to treat, and its overall survival (OS) is still below 50%. Although HR-NB is a heterogeneous disease, HR-NB patients are currently treated in a similar fashion. Through unsupervised biclustering, we further stratified HR-NB patients into two reproducible and clinically distinct subtypes, including an ultra-high risk neuroblastoma (UHR-NB) and high risk neuroblastoma (HR-NB). The UHR-NB subtype consistently had the worst OS in multiple independent cohorts (<inline-formula> <math display="inline"> <semantics> <mrow> <mi>P</mi> <mo><</mo> <mn>0</mn> <mo>.</mo> <mn>008</mn> </mrow> </semantics> </math> </inline-formula>). Out of 283 neuroblastoma-specific immune genes that were used for stratification, 39 of them were differentiated in UHR-NB, including four upregulated and 35 downregulated, as compared to HR-NB. The four UHR-NB upregulated genes (ADAM22, GAL, KLHL13 and TWIST1) were all upregulated in MYCN amplified neuroblastoma in 5 additional cohorts. TWIST1 and ADAM22 were also positively correlated with cancer stage, while GAL was an independent OS predictor in addition to MYCN and age. Furthermore, we identified 26 commonly upregulated and 311 downregulated genes in UHR-NB from all 4723 immune-related genes. While 43 KEGG pathways with molecular functions were enriched in the downregulated immune-related genes, only the P53 signaling pathway was enriched in the upregulated ones, which suggested that UHR-NB was a TP53 related subtype with reduced immune activities.https://www.mdpi.com/2072-6694/12/7/1739ultra-high risk neuroblastomaclinically distinct subtypesimmune-related gene signaturesprognostic markersbiclusteringTP53 signaling
collection DOAJ
language English
format Article
sources DOAJ
author Zhenqiu Liu
Christa N. Grant
Lidan Sun
Barbara A. Miller
Vladimir S. Spiegelman
Hong-Gang Wang
spellingShingle Zhenqiu Liu
Christa N. Grant
Lidan Sun
Barbara A. Miller
Vladimir S. Spiegelman
Hong-Gang Wang
Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
Cancers
ultra-high risk neuroblastoma
clinically distinct subtypes
immune-related gene signatures
prognostic markers
biclustering
TP53 signaling
author_facet Zhenqiu Liu
Christa N. Grant
Lidan Sun
Barbara A. Miller
Vladimir S. Spiegelman
Hong-Gang Wang
author_sort Zhenqiu Liu
title Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
title_short Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
title_full Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
title_fullStr Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
title_full_unstemmed Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
title_sort expression patterns of immune genes reveal heterogeneous subtypes of high-risk neuroblastoma
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-06-01
description High risk neuroblastoma (HR-NB) remains difficult to treat, and its overall survival (OS) is still below 50%. Although HR-NB is a heterogeneous disease, HR-NB patients are currently treated in a similar fashion. Through unsupervised biclustering, we further stratified HR-NB patients into two reproducible and clinically distinct subtypes, including an ultra-high risk neuroblastoma (UHR-NB) and high risk neuroblastoma (HR-NB). The UHR-NB subtype consistently had the worst OS in multiple independent cohorts (<inline-formula> <math display="inline"> <semantics> <mrow> <mi>P</mi> <mo><</mo> <mn>0</mn> <mo>.</mo> <mn>008</mn> </mrow> </semantics> </math> </inline-formula>). Out of 283 neuroblastoma-specific immune genes that were used for stratification, 39 of them were differentiated in UHR-NB, including four upregulated and 35 downregulated, as compared to HR-NB. The four UHR-NB upregulated genes (ADAM22, GAL, KLHL13 and TWIST1) were all upregulated in MYCN amplified neuroblastoma in 5 additional cohorts. TWIST1 and ADAM22 were also positively correlated with cancer stage, while GAL was an independent OS predictor in addition to MYCN and age. Furthermore, we identified 26 commonly upregulated and 311 downregulated genes in UHR-NB from all 4723 immune-related genes. While 43 KEGG pathways with molecular functions were enriched in the downregulated immune-related genes, only the P53 signaling pathway was enriched in the upregulated ones, which suggested that UHR-NB was a TP53 related subtype with reduced immune activities.
topic ultra-high risk neuroblastoma
clinically distinct subtypes
immune-related gene signatures
prognostic markers
biclustering
TP53 signaling
url https://www.mdpi.com/2072-6694/12/7/1739
work_keys_str_mv AT zhenqiuliu expressionpatternsofimmunegenesrevealheterogeneoussubtypesofhighriskneuroblastoma
AT christangrant expressionpatternsofimmunegenesrevealheterogeneoussubtypesofhighriskneuroblastoma
AT lidansun expressionpatternsofimmunegenesrevealheterogeneoussubtypesofhighriskneuroblastoma
AT barbaraamiller expressionpatternsofimmunegenesrevealheterogeneoussubtypesofhighriskneuroblastoma
AT vladimirsspiegelman expressionpatternsofimmunegenesrevealheterogeneoussubtypesofhighriskneuroblastoma
AT honggangwang expressionpatternsofimmunegenesrevealheterogeneoussubtypesofhighriskneuroblastoma
_version_ 1724648910813659136